Objectives
To evaluate the associations between intakes of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) and the intermediate and advanced stages of age-related macular degeneration (AMD).
Design
Prospective cohort study.
Participants
We followed 75,889 women from the Nurses’ Health Study and 38,961 men from the Health Professionals Follow-Up Study who were at least 50 years old from 1984 to 2012 and 1986 to 2010, respectively. Cohort participants are mostly white (≥ 95%).
Methods
We assessed dietary intake by a validated food frequency questionnaire (FFQ) at baseline and every four years. We calculated cumulative average intakes of EPA and DHA from FFQs and also computed predicted erythrocyte and plasma scores directly from food intake using regression models. Cox proportional hazards models were used to compute the associations with AMD outcomes.
Main Outcome Measures
We confirmed 1,589 incident intermediate and 1,356 advanced AMD cases (primarily neovascular AMD) with a visual acuity of 20/30 or worse due primarily to AMD by medical record review.
Results
For intermediate AMD, the pooled hazard ratio (HR) between the two cohorts for DHA comparing the extreme quintiles of intake was 0.78 (95% CI, 0.66 – 0.92; p trend, 0.008) and for EPA + DHA was 0.83 (95% CI, 0.71 – 0.98; p trend, 0.03). The pooled HR for fatty fish comparing ≥ 5 servings/week to almost never was 0.61 (95% CI, 0.46 – 0.81; p trend, < 0.001). For advanced AMD, the pooled HR for DHA was 1.01 (95% CI, 0.84 – 1.21; p trend, 0.75) and for fatty fish was 0.80 (95% CI, 0.59 – 1.08; p trend, 0.11). Secondary analyses using predicted erythrocyte and plasma scores of EPA and DHA yielded slightly stronger inverse associations for intermediate AMD and similar results for advanced AMD.
Conclusions
Higher intakes of EPA and DHA may prevent or delay the occurrence of visually significant intermediate AMD. However, the totality of current evidence for EPA and DHA and advanced AMD is discordant, though there was no association with advanced AMD in the present study.